Neurobiology of Aging
Volume 31, Issue 8 , Pages 1419-1428 , August 2010

Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline

  • J. Nettiksimmons

      Affiliations

    • Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Davis, CA 95616, USA
    • ,
  • D. Harvey

      Affiliations

    • Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Davis, CA 95616, USA
    • ,
  • J. Brewer

      Affiliations

    • Departments of Radiology and Neurosciences, University of California, San Diego, La Jolla, CA 92093-0949, USA
    • ,
  • O. Carmichael

      Affiliations

    • Department of Neurology, University of California, Davis, Davis, CA 95616, USA
    • ,
  • C. DeCarli

      Affiliations

    • Department of Neurology, University of California, Davis, Davis, CA 95616, USA
    • ,
  • C.R. Jack Jr

      Affiliations

    • Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA
    • ,
  • R. Petersen

      Affiliations

    • Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA
    • ,
  • L.M. Shaw

      Affiliations

    • Institute on Aging, Alzheimer's Disease Core Center, Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • J.Q. Trojanowski

      Affiliations

    • Center for Imaging of Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA
    • ,
  • M.W. Weiner

      Affiliations

    • Center for Imaging of Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA
    • ,
  • L. Beckett

      Affiliations

    • Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Davis, CA 95616, USA
    • Corresponding Author InformationCorresponding author at. Tel.: (530) 754-7161; fax: (530) 752-3239
    • ,
  • The Alzheimer's Disease Neuroimaging Initiative

      Affiliations

    • Data used in the preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (www.loni.ucla.edu/ADNI). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators is available at www.loni.ucla.edu/ADNI\Collaboration\ADNI_Manuscript_Citations.pdf.

Received 14 February 2010 ,Revised 19 April 2010 ,Accepted 23 April 2010.

References 

  1. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. BMJ. 1999;67:66–72
  2. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;23:198–205
  3. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3:186–191
  4. Carlson NE, Moore MM, Dame A, Howieson D, Silbert LC, Quinn JF, et al. Trajectories of brain loss in aging and the development of cognitive impairment. Neurology. 2008;70:828–833
  5. Clark CM, Davatzikos C, Borthakur A, Newberg A, Leight S, Lee VM, et al. Biomarkers for early detection of Alzheimer pathology. Neuro Signals. 2008;16:11–18
  6. De Meyer, G., Shapiro, F., Vanderstichele, H., Vanmechelen, E., Engleborghs, B., De Deyn, P.-P., Coart, E., Hanson, O., Minthon, L., Zetterberg, H., Blennow, K., Shaw, L.M., Trojanowski, J.Q., The Alzheimer's Disease Neuroimaging Initiative, 2010. Diagnosis-independent Alzheimer's disease biomarker signature in cognitively normal elderly people. Arch Neurol. [in press].
  7. Evans DA. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289
  8. Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, et al. Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol. 2009;65:176–183
  9. Fennema-Notestine C, Hagler DJ, McEvoy LK, Fleisher AS, Wu EH, Karow DS, et al. Structural MRI biomarkers for preclinical and mild Alzheimer's Disease. Human Brain Mapping. 2009;30:3238–3253
  10. Hampel H, Burger KB, Teipel SJ, Bokde ALW, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease (Alzheimers Dement 4, Nos). 1, 38–48 J Alzheimer's Assoc. 2007;4(1):38–48
  11. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74:1206–1209
  12. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122
  13. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen P, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119–128
  14. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963–974
  15. Maddalena A, Papassotiropoulos A, Muller-Tillmanns B, Jung HH, Hegi T, Nitsch RM, et al. Biochemical Diagnosis of Alzheimer Disease by Measuring the Cerebrospinal Fluid Ratio of Phosphorylated tau Protein to beta-Amyloid Peptide42. Arch Neurol. 2003;60:1202
  16. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 2009;45:S3–S15
  17. J.Q. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, et al. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am. 2005;15:869–877
  18. Mueller SG, Weiner MW, Thal LJ, Petersen JCR, Jagust W, Trojanowski JQ, et al. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) (Alzheimers Dement 1, Nos). 1, 55–66 J Alzheimer's Assoc. 2005;1(1):55–66
  19. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain. 2008;131:2443–2454
  20. Petersen RC, Robers RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. Mild Cognitive Impairment: Ten years later. Arch. Neurol. 2009;66:1477–1455
  21. Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74:201–209
  22. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009;
  23. Rand WM. Objective criteria for the evaluation of clustering methods. J Am Stat Assoc. 1971;66:846–850
  24. SAS Institute, Inc. SAS/STATÒ Version 9.0. Cary, NC: SAS Institute, Inc; 2004;
  25. Schwarz C, Fletcher E, deCarli C, Carmichael O. Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Inf Proc Med Imaging. 2009;21:239–251
  26. Shaw LM, Korecka M, Clark CM, Lee VM-Y, Trojanowski JQ. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov. 2007;6:295–303
  27. Shaw LM. PENN Biomarker Core of the Alzheimer's Disease Neuroimaging Initiative. Neuro Signals. 2008;16:19–23
  28. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen P, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol. 2009;65:403–413
  29. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine?. Food Nutr Bull. 2008;(29 suppl):S143
  30. Stomrud E, Hansson O, Blennow K, Minthon L, Londos E. Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. Dement Geriatr Cogn Disord. 2007;24:118–124
  31. Ward J. Hierarchical Grouping to optimize an objective function. J Am Stat Assoc. 1963;58:236–244

PII: S0197-4580(10)00200-9

doi: 10.1016/j.neurobiolaging.2010.04.025

Neurobiology of Aging
Volume 31, Issue 8 , Pages 1419-1428 , August 2010

Article Tools

* Image Usage & Resolution